This observation suggests that tau levels in L1CAM+ EVs could serve as a potential biomarker in combined use with α-synuclein, for distinguishing PD from other mimic diseases and aiding in its diagnosis [67]. The gene discussed is MAPT; the disease is Parkinson disease.